3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Thoracic
2
Gastrointestinal
1
Conditions
Lung Neoplasms
2
Solitary Pulmonary Nodule
1
Disease
1
Interventions
Carboplatin
88
pembrolizumab
77
Pemetrexed
65
Cisplatin
56
Paclitaxel
33
Docetaxel
31
durvalumab
28
atezolizumab
28
Nivolumab
28
Specimen Handling
25
Magnetic Resonance Spectroscopy
20
Gemcitabine
19
osimertinib
18
130-nm albumin-bound paclitaxel
18
Etoposide
17
Radiotherapy
14
Cetuximab
14
Platinum
12
Taxes
11
Immunoglobulin G
10
1,2-diaminocyclohexaneplatinum II citrate
10
Radiation
9
Ipilimumab
9
Disulfides
9
Bevacizumab
9
amivantamab
8
Topotecan
8
fludarabine
7
Ramucirumab
7
Radiosurgery
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Hematologic Tests
×
Thoracic
×
30 days
×
Clear all
NCT07623473
2026-06-03
NIMBLE
Herlev and Gentofte Hospital
Recruiting
1,800 enrolled
NCT01687647
2026-05-29
AMORCE-CBP
University Hospital, Caen
Phase 3
Terminated
463 enrolled